These results are consistent with our previous findings that D-4F treatment of T1DM rats decreases MMP9 and proinflammatory mediators TNFα, TLR-4 and increases anti-inflammatory M2-macrophage polarization (45). The gene discussed is MMP9; the disease is type 1 diabetes mellitus.